Bhatia Sangeeta N. 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Aug 29, 2025
Insider Transaction Report
Form 4
Bhatia Sangeeta N.
Director
Transactions
- Sale
Common Stock
2025-08-27$386.69/sh−266$102,860→ 4,565 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025.